We are Intas Pharmaceuticals, a leading, vertically integrated global pharmaceutical company headquartered in India, with advanced formulation development, manufacturing, and marketing capabilities. Our success and unparalleled growth lie in the clinical execution of strategic moves in manufacturing, R&D, biotechnology and global business operations.

Showing the single result

Show sidebar
Show 9 12 18 24
Clear filters
-13%
SYNOPET
Add to compare
Quick view

SYNOPET POWDER – Joint Support for Pets

, , ,
Original price was: ₹750.Current price is: ₹650.
Select options This product has multiple variants. The options may be chosen on the product page

With a global turnover of $2.3 billion, we have a strong presence in key markets across 85+ countries. We spearhead every endeavour with the power of human expertise, innovative research and advanced technology, aiming to set new benchmarks in global healthcare continually. Each of our 16 ultra-modern facilities is a testament to our uncompromising quality standards. All these facilities are approved by major global regulatory agencies including the US-FDA, UK-MHRA, TGA (Australia), MCC (S. Africa), TPD (Canada), MEB (Netherlands), AFI (Belgium), FDA (Nordic Countries), ANVISA (Brazil), and WHO-GMP. Intas was the first company to receive European Health Authority accreditation for its biologics manufacturing facility in India. While we have a strong presence in CNS, CVS, and chronic markets in India, we specialize and offer a wide range of products in Oncology and other hospital-based therapeutic segments in the EU and US.